TY  - GEN
AU  - Schmeling,Heinrike
AU  - Minden,Kirsten
AU  - Foeldvari,Ivan
AU  - Ganser,Gerd
AU  - Hospach,Tony
AU  - Horneff,Gerd
TI  - Efficacy and safety of adalimumab as the first and second biologic agent in juvenile idiopathic arthritis: the German Biologics JIA Registry
SN  - 2326-5205
PY  - 2014///1028
KW  - Adalimumab
KW  - Adolescent
KW  - Antibodies, Monoclonal, Humanized
KW  - adverse effects
KW  - Antirheumatic Agents
KW  - Arthritis, Juvenile
KW  - drug therapy
KW  - Biological Products
KW  - Child
KW  - Female
KW  - Germany
KW  - Humans
KW  - Male
KW  - Registries
KW  - Severity of Illness Index
KW  - Treatment Outcome
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1002/art.38741
ER  -